Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops Revenue Estimates
PYXSPyxis Oncology(PYXS) Zacks Investment Research·2024-05-14 21:41

Pyxis Oncology, Inc. (PYXS) came out with a quarterly loss of 0.06pershareversustheZacksConsensusEstimateofalossof0.06 per share versus the Zacks Consensus Estimate of a loss of 0.27. This compares to loss of 0.54pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof77.780.54 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 77.78%. A quarter ago, it was expected that this company would post a loss of 0.49 per share when it actually produced a loss of $0.33, delivering a surprise of 32.65%. Over the last four quarters, the company has s ...